Michael Lehmann Appointed Patheon's President of Global Pharmaceutical Development Services
Historical Stock Chart
5 Years : From Feb 2013 to Feb 2018
TORONTO, Nov. 1, 2012 /PRNewswire/ - Patheon Inc. (TSX: PTI), a leading provider of contract development and
manufacturing services to the global pharmaceutical industry, today
announced that Michael Lehmann has joined the company as President of
Global Pharmaceutical Development Services (PDS).
"I am pleased to be welcoming Mike and getting him quickly integrated
with Patheon's leadership team," stated James C. Mullen, Patheon's Chief Executive Officer. "He is a highly accomplished
senior executive with a proven track record in the healthcare, life
sciences and drug development sectors. Patheon will significantly
benefit from his recognized ability to drive both growth and
competitiveness in varying market conditions, and I look forward to his
future contributions as we continue to transform our business to
provide the leading customer experience."
Mr. Lehmann was most recently Corporate Senior Vice President and
General Manager of the Global Early Development business of Covance
from 2005 to 2012, which is one of the world's largest drug development
services companies. In his role, he was responsible for global early
development and P&L management; and key accomplishments included
executive leadership in strategic deals between Covance, Lilly and
Sanofi. Prior to joining Covance, Mr. Lehmann worked for 17 years at
GE's Healthcare in key operational and management roles. His career
started with a focus in client services, managing large call centers
for both external customers and repair technicians. In 1998, he was
tasked with assisting in the integration of the company's MECON
acquisition, operational and clinical performance optimization
services. Mr. Lehmann progressed through various other comparable
roles to emerge as the General Manager of the Multivendor Solutions
business in 2003, where he was responsible for facilitating the upkeep
and repair of other OEM diagnostic imaging equipment and accessories
with complete P&L responsibilities.
Mr. Lehmann holds an M.B.A from Marquette University and a B.S in
mechanical engineering from the Catholic University of America.
About Patheon Inc.
Patheon Inc. (TSX: PTI) is a leading global provider of contract
development and manufacturing services to the global pharmaceutical
industry. The company provides the highest quality products and
services to approximately 300 of the world's leading pharmaceutical and
biotechnology companies. Patheon's services range from preclinical
development through commercial manufacturing of a full array of solid
and sterile dosage forms.
The company's comprehensive range of fully integrated Pharmaceutical
Development Services includes pre-formulation, formulation, analytical
development, clinical manufacturing, scale-up and commercialization.
The company's integrated development and manufacturing network of nine
manufacturing facilities and nine development centers across North
America and Europe, enables customer products to be launched with
confidence anywhere in the world. For more information visit www.Patheon.com.
SOURCE Patheon Inc.